GlassScriptPhysician profile
Scott J Zuccala
NPI 1487657094
$1,547.37
in general payments reported to CMS, 2019-2025
22 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $105 · 2021: $231 · 2022: $301 · 2023: $253 · 2024: $422 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $319.18 | 2020-2025 | Evenity, Prolia, Prolia |
| Mayne Pharma Commercial LLC | $251.14 | 2022-2025 | |
| Abbvie INC. | $171.46 | 2020-2024 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $161.26 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $91.02 | 2020-2022 | |
| Exeltis, USA INC. | $70.63 | 2022-2025 | Slynd |
| Pfizer INC. | $65.19 | 2021 | |
| Lilly USA, LLC | $54.13 | 2024 | Jardiance, Zepbound |
| Novo Nordisk INC | $45.62 | 2023-2024 | Wegovy |
| Hologic Sales and Service, LLC | $44.70 | 2024-2025 | Aptima |
| Coopersurgical, INC. | $39.07 | 2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $38.39 | 2022-2023 | Twirla |
| Evofem Biosciences, INC. | $34.07 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $28.77 | 2021-2022 | |
| Myovant Sciences INC. | $25.42 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.06 | 2021 | |
| Daiichi Sankyo INC. | $17.15 | 2024 | Injectafer |
| Millicent US INC | $16.95 | 2025 | Femlyv |
| Scynexis, INC. | $14.14 | 2022 | |
| Avion Pharmaceuticals | $13.96 | 2020 | |
| Merck Sharp & Dohme LLC | $12.63 | 2022 | |
| Allergan, INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Zuccala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.